Credit: Graphic created by M.E. Newman, Johns Hopkins Medicine, using public domain images, including the scanning electron micrograph of E. coli courtesy of the National Institute of Allergy and Infectious Diseases
PCORI has awarded $10 million to Johns Hopkins Medicine to see if early transition to oral antibiotic therapy from IV administration improves outcomes for patients with gram-negative bloodstream infections, such as the pathogenic Escherichia coli seen in the background.